Travere Therapeutics' Inventory Average fell 21.85% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 21.85%. This contributed to the annual value of $7.8 million for FY2024, which is 12.04% up from last year.
According to the latest figures from Q3 2025, Travere Therapeutics' Inventory Average is $4.8 million, which was up 20.14% from $4.0 million recorded in Q2 2025.
Over the past 5 years, Travere Therapeutics' Inventory Average peaked at $19.8 million during Q3 2023, and registered a low of $4.0 million during Q2 2025.
For the 3-year period, Travere Therapeutics' Inventory Average averaged around $8.3 million, with its median value being $6.2 million (2024).
Per our database at Business Quant, Travere Therapeutics' Inventory Average surged by 164.84% in 2023 and then crashed by 68.81% in 2024.
Travere Therapeutics' Inventory Average (Quarterly) stood at $7.0 million in 2021, then fell by 15.14% to $5.9 million in 2022, then skyrocketed by 155.36% to $15.1 million in 2023, then crashed by 58.40% to $6.3 million in 2024, then fell by 21.85% to $4.8 million in 2025.
Its Inventory Average stands at $4.8 million for Q3 2025, versus $4.0 million for Q2 2025 and $5.1 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value